Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-09-20
1991-09-24
Doll, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530331, 530330, 530800, A61K 3702, C07K 508
Patent
active
050514040
ABSTRACT:
Tripeptides having hypotensive activity, defined by the following general formula:
REFERENCES:
patent: 3821188 (1974-06-01), McKinley et al.
patent: 3917578 (1975-11-01), Immer et al.
patent: 4216209 (1980-08-01), Bellini et al.
patent: 4374120 (1983-02-01), Soini
patent: 4565790 (1986-01-01), Hemmila
patent: 4619916 (1986-10-01), Di Stazio et al.
patent: 4666888 (1987-05-01), Raddatz et al.
patent: 4713368 (1987-12-01), Sisto et al.
International Review of Science, vol. 6, Organic Chemistry Series Two, pp. 140-141, (edited by) Rydon.
Analytical Biochemistry 137, 335-343 (1984)-Hemmila et al., "Europium as a Label in Time-Resolved Immunofluorometric Assays".
De Luca Giovanna
Di Stazio Giovanni
Politi Vincenzo
Sisto Alessandro
Verdini Antonio S.
Doll John
Eniricerche S.p.A.
Polifarma S.p.A.
Wessendorf T. D.
LandOfFree
Tripeptide compounds having hypotensive activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tripeptide compounds having hypotensive activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tripeptide compounds having hypotensive activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1696683